
Dialysis access graft for complex central venous cases from Merit Medical
The HeRO Graft is a fully subcutaneous hybrid vascular access device used for hemodialysis patients with central venous occlusion who cannot receive conventional upper-arm fistulas or grafts. It combines an ePTFE graft with a nitinol-reinforced venous outflow component that bypasses stenosed central veins to the right atrium. Unlike VenoStent's investigational bioabsorbable wrap intended to support maturing fistulas, HeRO is immediately available, surgically implanted, and reimbursed today. It serves a narrower rescue-access population rather than prophylactic support of new fistulas. Long-term data show acceptable patency but higher infection rates than native vessels. Relevance to VenoStent searchers is high when central venous disease precludes standard options.
Merit Medical, founded in 1987, manufactures proprietary disposable medical devices for interventional, diagnostic and therapeutic procedures, with dedicated Dialysis Access solutions that advance patient care and support positive outcomes. The company serves hospitals and physicians worldwide through evolving product portfolios, clinician education, and resources focused on dialysis access alongside other procedural categories. Merit employs approximately 7,000 people globally and emphasizes procedural solutions including kits, access technologies, and training designed by physicians.
Free

Culturally responsive mental health resources and therapist directory for Black women and girls.

NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Online therapy for teens and parents via text, phone, and video from licensed therapists.